HomeGreater Than Icon
Sunrest Lifescience LtdGreater Than Icon
Sunrest Lifescience Ltd Financials
Company Logo

Sunrest Lifescience Ltd Financial Statement

Sunrest Lifescience Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2023
Revenue6.84
Operating Expense6.19
Net Profit1.23
Net Profit Margin17.98
Earning Per Share4.12
EBIDTA0.65
Effective Tax Rate-93.85

Sunrest Lifescience Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual24.64
Operating Expenses Annual21.74
Operating Profit Annual2.93
Interest Annual0.06
Depreciation0.13
Net Profit Annual2.04
Tax Annual0.70

Sunrest Lifescience Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning0.48
Cash Flow from Operations1.15
Cash Flow from Investing-0.03
Cash Flow from Financing-1.15
Cash Flow at the End0.45

Sunrest Lifescience Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)11.89
PBIT Margin (%)11.36
PBT Margin (%)-178.05
Net PROFIT Margin (%)8.28
Return On Networth / Equity (%)97.61
Return On Networth /Employed (%)58.58
Return On Assets (%)42.64
Total Debt / Equity (X)1.29
Asset Turnover Ratio (%)5.15

Sunrest Lifescience Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual0.35
Total Current Assets Annual16.30
Non Current Assets Annual0.41
Total Shareholders Funds Annual3.11
Total Assets Annual16.71

Sunrest Lifescience Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Sunrest Lifescience Ltd has a market capitalization of 26.20 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Sunrest Lifescience Ltd is debt-free with a debt-to-equity ratio of 0.43.
In FY 2023 , Sunrest Lifescience Ltd recorded a total revenue of approximately 29.48 Cr marking a significant milestone in the company's financial performance.
Sunrest Lifescience Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.0% annually, respectively..
Sunrest Lifescience Ltd's current PE ratio is 113.91.
Sunrest Lifescience Ltd's ROCE averaged 27.3% from the FY ending March 2022 to 2024, with a median of 24.6%. It peaked at 53.3% in March 2023, reflecting strong capital efficiency over the period..
Sunrest Lifescience Ltd's latest EBIT is Rs. 0.81 Cr, surpassing the average EBIT of Rs. 1.56 Cr over the 5 years..